Polymeric drugs based on conjugates of synthetic and natural macromolecules. I. Synthesis and physico-chemical characterisation
Language English Country Netherlands Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
10640646
DOI
10.1016/s0168-3659(99)00141-8
PII: S0168365999001418
Knihovny.cz E-resources
- MeSH
- Antigens, Surface metabolism MeSH
- Time Factors MeSH
- Doxorubicin pharmacokinetics MeSH
- Lymphoma drug therapy MeSH
- Macromolecular Substances MeSH
- Methacrylates chemical synthesis chemistry MeSH
- Molecular Sequence Data MeSH
- Mice, Inbred BALB C MeSH
- Mice, Inbred C57BL MeSH
- Mice MeSH
- Tumor Cells, Cultured MeSH
- Drug Carriers chemistry MeSH
- Oligopeptides chemistry MeSH
- Polymers chemistry MeSH
- Proteins chemistry MeSH
- Antibodies chemistry metabolism MeSH
- Antineoplastic Agents pharmacokinetics MeSH
- Amino Acid Sequence MeSH
- T-Lymphocytes MeSH
- In Vitro Techniques MeSH
- Binding Sites MeSH
- Structure-Activity Relationship MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Antigens, Surface MeSH
- Doxorubicin MeSH
- hydroxypropyl methacrylate MeSH Browser
- Macromolecular Substances MeSH
- Methacrylates MeSH
- Drug Carriers MeSH
- Oligopeptides MeSH
- Polymers MeSH
- Proteins MeSH
- Antibodies MeSH
- Antineoplastic Agents MeSH
This paper describes the synthesis, physico-chemical characteristics and results of selected biological tests of conjugates of antibodies or proteins with poly(HPMA) or with poly(HPMA) carriers of anti-cancer drug doxorubicin, designed for targeted cancer therapy. Two types of conjugates differing in the method of conjugation of polymer with protein were synthesized. In the first, protein is attached to the polymer via an oligopeptide sequence in the side chain of the polymer backbone and, in the second, the polymer is attached to protein via its end-chain functional group. Conjugation of an antibody with poly(HPMA) does not influence the binding activity of the antibody for cell surface antigen. The physico-chemical characteristics and biological activity of both systems depend on the detailed structure of the polymer, the type of antibody or protein moiety and the structure of the whole system.
References provided by Crossref.org
Polymer-Antimicrobial Peptide Constructs with Tailored Drug-Release Behavior
Octahedral Molybdenum Cluster-Based Nanomaterials for Potential Photodynamic Therapy
HPMA Copolymer-Based Nanomedicines in Controlled Drug Delivery
Selective Priming of Tumor Blood Vessels by Radiation Therapy Enhances Nanodrug Delivery
Plasmonic Hepatitis B Biosensor for the Analysis of Clinical Saliva
Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound